Medicare Enrolled

Dr. Barry Katz, MD

Gastroenterology · Altamonte Springs, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
623 MAITLAND AVENUE, Altamonte Springs, FL 32701
4078308661
In practice since 2005 (20 years)
NPI: 1427035120 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Katz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Katz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Katz

Dr. Barry Katz is a gastroenterology in Altamonte Springs, FL, with 20 years in practice. Based on federal Medicare data, Dr. Katz performed 9,864 Medicare services across 1,500 unique beneficiaries.

Between the years covered by Open Payments, Dr. Katz received a total of $12,393 from 53 pharmaceutical and/or device companies across 555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Katz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 3% volume in FL$ $12,393 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,864
Medicare services
Top 3% in FL for gastroenterology
1,500
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~493 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Vedolizumab infusion (Entyvio)7,200$17$66
Tissue pathology examination, moderate complexity913$25$150
Special stained specimen slides to examine tissue including interpretation and report477$52$150
Special stained specimen slides to identify organisms including interpretation and report254$65$200
Office visit, established patient (30-39 min)248$94$165
Upper GI endoscopy with biopsy186$72$625
Removal of polyps or growths of large bowel using an endoscope with mechanical snare139$210$1,095
Colonoscopy with biopsy96$104$804
New patient office visit (45-59 min)77$120$233
Colorectal cancer screening; colonoscopy on individual at high risk67$183$750
New patient office visit (30-44 min)54$76$161
Office visit, established patient (20-29 min)53$68$100
Administration of chemotherapy into vein, 1 hour or less36$98$472
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk29$183$750
Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm18$112$650
Ultrasound scan of organ tissue for measuring elasticity17$73$160
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.0% high complexity
4.4% medium
22.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,393
Total received (2018-2024)
Avg $1,770/year across 7 years
Top 13% in FL for gastroenterology
53
Companies
555
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,368 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,507
2023
$1,692
2022
$1,639
2021
$1,408
2020
$967
2019
$1,708
2018
$2,472

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,731
AbbVie, Inc.
$1,209
Janssen Biotech, Inc.
$1,053
AbbVie Inc.
$707
Takeda Pharmaceuticals U.S.A., Inc.
$640
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$628
Janssen Scientific Affairs, LLC
$564
PFIZER INC.
$539
QOL Medical, LLC
$500
Phathom Pharmaceuticals, Inc.
$479
Regeneron Healthcare Solutions, Inc.
$363
Intercept Pharmaceuticals, Inc.
$348
Gilead Sciences, Inc.
$346
Celgene Corporation
$328
GENZYME CORPORATION
$293
Amgen Inc.
$249
Micro-tech Endoscopy USA, Inc.
$214
Boston Scientific Corporation
$166
Allergan Inc.
$163
Synergy Pharmaceuticals Inc
$154
Ironwood Pharmaceuticals, Inc
$123
Medtronic, Inc.
$122
Merck Sharp & Dohme LLC
$122
Ferring Pharmaceuticals Inc.
$100
E.R. Squibb & Sons, L.L.C.
$95
RedHill Biopharma Inc.
$93
Echosens North America, Inc.
$91
UCB, Inc.
$81
VIVUS, Inc.
$81
Lilly USA, LLC
$65
Braintree Laboratories, Inc.
$63
Madrigal Pharmaceuticals
$57
Celltrion USA Inc.
$57
Daiichi Sankyo Inc.
$55
Covidien LP
$49
Ardelyx, Inc.
$48
INTERCEPT PHARMACEUTICALS, INC.
$46
Lucid Diagnostics Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$37
AstraZeneca Pharmaceuticals LP
$35
Allergan, Inc.
$31
IRONWOOD PHARMACEUTICALS, INC
$31
Mallinckrodt Hospital Products Inc.
$23
Fresenius Kabi USA, LLC
$22
AIMMUNE THERAPEUTICS, INC.
$22
Axonics, Inc.
$21
VIVUS LLC
$18
Alnylam Pharmaceuticals Inc.
$17
CONMED Corporation
$17
Evoke Pharma, Inc.
$16
Nestle HealthCare Nutrition Inc.
$16
Merck Sharp & Dohme Corporation
$14
Ethicon US, LLC
$13
Top 3 companies account for 32.2% of total payments
Associated products mentioned in payments ›
AMJEVITA · APRISO · AVSOLA · Aemcolo · All products · Amitiza · Axonics · CIMZIA · CLENPIQ · CONMED GENERATORS · CREON · CYLTEZO · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EXALT Model D · Entyvio · Epclusa · Fibroscan · GENERAL BIOPSY · GI GENIUS · GI Genius · GIMOTI · GIVLAARI · HUMIRA · Humira · IBSRELA · INFLECTRA · INJECTAFER · LINX Reflux Management System · LINZESS · Linzess · Livdelzi · MAVYRET · MOTEGRITY · MOVANTIK · MOVIPREP · Mavyret · Motegrity · Movantik · OCALIVA · OMVOH · PANCREAZE · PLENVU · Pancreaze · PillCam · QULIPTA · REBYOTA · RELISTOR · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP · SUTAB · Sucraid · TERLIVAZ · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VELSIPITY · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFIXAN · YUFLYMA · ZENPEP · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $126 per 100 Medicare services performed
Looking for a gastroenterology in Altamonte Springs?
Compare gastroenterologys in the Altamonte Springs area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
112
Per 100K population
23.6
County median income
$83,030
Nearest hospital
ASPIRE HEALTH PARTNERS
7.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Katz is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and high industry engagement (low-engagement, top 13%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Katz experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Katz performed 7,200 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Katz receive payments from pharmaceutical companies?
Yes. Dr. Katz received a total of $12,393 from 53 companies across 555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Katz's costs compare to other gastroenterologys in Altamonte Springs?
Dr. Katz's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Katz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →